Amgen Inc expected to post earnings of $5.01 a share - Earnings Preview - TradingView

Amgen Inc AMGN is expected to show a rise in quarterly revenue when it reports results on November 4 for the period ending September 30 2025 The Thousand Oaks California-based company is expected to report a 5.5% increase in revenue to $8.967 billion from $8.5 billion a year ago, according to the mean estimate from 22 analysts, based on LSEG data. (Sales/Revenue Majority Basis is on Total Revenue) ​LSEG's mean analyst estimate for Amgen Inc is for earnings of $5.01 per share. The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 15 "hold" and 3 "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. ​ Wall Street's median 12-month price target for Amgen Inc is $315.00, about 7.3% above its last closing price of $292.00